StonvexLoading…
StonvexCore line items from DAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $7.50B | $1.92B | $1.94B | $1.78B |
Operating Income | $139.00M | Not available | Not available | Not available |
Net Income | $85.00M | $83.00M | $27.00M | $25.00M |
EPS (Diluted) | $0.64 | $0.64 | $0.19 | $0.17 |
Total Assets | $7.81B | Not available | Not available | Not available |
Total Liabilities | $6.91B | Not available | Not available | Not available |
Cash & Equivalents | $469.00M | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $298.00M | Not available | Not available | Not available |
Shares Outstanding | 112.28M | 130.80M | 143.80M | 145.60M |